Amiodaronem indukované postižení plic u pacienta s fibrilací síní

HUDEC, Martin, Petra VYSOČANOVÁ, Vojtěch BRÁZDIL, Martin POLOCZEK, Martin HETMER, Jiřina LITTLE, Martina DOUBKOVÁ a Petr KALA. Amiodaronem indukované postižení plic u pacienta s fibrilací síní. Vnitřní lékařství. Praha: Česká lékařská společnost J. E. Purkyně, 2021, roč. 67, č. 7, s. "E18"-"E23", 6 s. ISSN 0042-773X. Dostupné z: https://dx.doi.org/10.36290/VNL.2021.116.

Základní údaje

• Originální název: Amiodaronem indukované postižení plic u pacienta s fibrilací síní
• Název anglicky: Amiodarone induced pulmonary toxicity
• Autoři: HUDEC, Martin (203 Česká republika, garant, domácí), Petra VYSOČANOVÁ (203 Česká republika, domácí), Vojtěch BRÁZDIL (203 Česká republika, domácí), Martin POLOCZEK (203 Česká republika, domácí), Martin HETMER (203 Česká republika), Jiřina LITTLE (203 Česká republika), Martina DOUBKOVÁ (203 Česká republika, domácí) a Petr KALA (203 Česká republika, domácí).
• Vydání: Vnitřní lékařství, Praha, Česká lékařská společnost J. E. Purkyně, 2021, 0042-773X.

Další údaje

• Originální jazyk: čeština
• Typ výsledku: Článek v odborném periodiku
• Obor: 30203 Respiratory systems
• Stát vydavatele: Česká republika
• Utajení: není předmětem státního či obchodního tajemství
• WWW: URL
• Kód RIV: RIV/00216224:14110/21:00128163
• Organizační jednotka: Lékařská fakulta
• Doi: http://dx.doi.org/10.36290/VNL.2021.116
• Klíčová slova česky: AIPT; Amiodarone; Amiodarone induced pulmonary toxicity; Amiodarone lung
• Klíčová slova anglicky: AIPT; Amiodarone; Amiodarone induced pulmonary toxicity; Amiodarone lung
• Štítky: rivok
• Příznaky: Recenzováno

Anotace

Amiodarone is one of the more frequently used drugs in the treatment of supraventricular and ventricular arrhythmias. Many adverse effects, more or less serious, are associated with its administration. Amiodaron-induced pulmonary toxicity (AIPT) is quite rare but represents one of the most severe adverse effects with high mortality. We present an 80 years old patient, who used amidorane due to paroxysmal atrial fibrillation for several years. Within 3 months, he was repeatedly hospitalized for a bilateral pneumonia. Eventually, AIPT was diagnosed. Early diagnosis, proper therapy of AIPT and changed antiarrhythmic therapy has significantly improved the clinical status of our patient. In this case we demonstrate typical clinical presentations of AIPT as well as the most common diagnostic procedures and recommended treatment methods. Finally, some other commonly used therapeutical options for supraventricular arrhythmias are mentioned. Future options are outlined. © 2021, SOLEN s.r.o.. All rights reserved.

Anotace anglicky

Amiodarone is one of the more frequently used drugs in the treatment of supraventricular and ventricular arrhythmias. Many adverse effects, more or less serious, are associated with its administration. Amiodaron-induced pulmonary toxicity (AIPT) is quite rare but represents one of the most severe adverse effects with high mortality. We present an 80 years old patient, who used amidorane due to paroxysmal atrial fibrillation for several years. Within 3 months, he was repeatedly hospitalized for a bilateral pneumonia. Eventually, AIPT was diagnosed. Early diagnosis, proper therapy of AIPT and changed antiarrhythmic therapy has significantly improved the clinical status of our patient. In this case we demonstrate typical clinical presentations of AIPT as well as the most common diagnostic procedures and recommended treatment methods. Finally, some other commonly used therapeutical options for supraventricular arrhythmias are mentioned. Future options are outlined. © 2021, SOLEN s.r.o.. All rights reserved.